Fundz

Cagent Vascular Appoints Paul Wilson as Chief Commercial Officer to Lead Commercial Strategy

PRIVATEMar 04, 2025

Position

Chief Commercial Officer

Company

Cagent Vascular

Paul Wilson
pwilson@cagentvascular.com
WayneHealthcareHealth Care

Description

Cagent Vascular, Inc has announced the appointment of Paul Wilson as Chief Commercial Officer (CCO). In his role, Mr Wilson will lead the company’s commercial strategy, overseeing sales, marketing, clinical programming, and business development initiatives to expand awareness, accelerate growth, and strengthen market positioning of Cagent Vascular’s proprietary serration balloon technology.

Who to call at Cagent Vascular, and when

A new leader at Cagent Vascular brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Cagent Vascular raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cagent Vascular, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cagent Vascular. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cagent Vascular

Location

150 STRAFFORD AVENUE

Wayne, Pennsylvania, United States

About

Cagent Vascular has developed and commercialized its novel angioplasty balloon with Serration Technology to treat blocked arteries in the leg or Peripheral Artery Disease (PAD) and Chronic Limb Threatening Ischemia (CLTI). The Serranator PTA Serration Balloon Catheter is the first and only angioplasty balloon with serration technology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cagent Vascular changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Robert
Senior decision-maker at this company
••••••••@••••••••

See Robert's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Cagent Vascular's next move

Learn about Strategic plan

Cagent Vascular changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.